• About
  • Subscribe
  • Advertise
  • Contact
Saturday, December 13, 2025
Newsletter
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
Home Local

ZEISS launches ClearView Finished Single Vision lenses

by Myles Hume
August 23, 2022
in Business, Company updates & acquisitions, Lenses, Local, News, Products
Reading Time: 3 mins read
A A
ZEISS says it has re-examined industry practices in single vision lens category.

ZEISS says it has re-examined industry practices in single vision lens category.

Share on FacebookShare on Twitter

ZEISS is “raising the standard of stock lenses” with the launch of its ClearView Finished Single Vision (FSV) lenses, which it says brings many aspects of freeform lens design to the FSV lens category.

According to the company, single vision is the most sold ophthalmic lens design, with the vast majority of these lenses being FSV lenses. However, it says many FSV lenses perform poorly with respect to their peripheral optics due to the lens design itself.

“The central power of a lens can be produced by an almost infinite range of lens forms. Lens design choices not only make a big difference in what lens aesthetics and wearing comfort can be achieved, but have a significant impact on its optical performance, particularly in the lens periphery,” ZEISS stated.

“Better optical performance across the entire lens can only be achieved by applying a higher complexity to the lens design optimisation.”

When ZEISS pioneered freeform technology for ophthalmic lenses, freeform single vision Rx lenses could overcome these problems, using more complex shapes, the company stated.

Freeform technology meant the lens shape could be optimised to give the best optics for each individual prescription while delivering very flat and thin lenses. According to ZEISS, this resulted in a new class of single vision lenses.

The lens power is optimised using 700 free parameters across one entire quadrant of the lens, which is then mirrored two times to cover the entire lens surface.

Recently, ZEISS said it decided to re-examine industry practices in single vision, challenging why the majority of single vision wearers – those wearing FSV lenses – could not get the visual benefits of freeform lens design.

“ZEISS has now identified a way to get these complex freeform lens designs onto FSV lenses. The advanced freeform lens design in ZEISS ClearView FSV uses point-by-point optimisation of the lens surface,” the company said.

“The lens power is optimised using 700 free parameters across one entire quadrant of the lens, which is then mirrored two times to cover the entire lens surface. The result is a FSV lens design that is both very thin and flat, and achieves excellent optics – with clear viewing from the lens centre to the periphery. A game-changer for optics.”

ZEISS products and training manager Ms Elmarie Pretorius said the company was transforming the single vision market by bringing many aspects of freeform lens design to the FSV lens category.

“Freeform lens design combined with the ClearForm technology used in ZEISS ClearView FSV enables complex lens shapes that were previously only possible in surfaced single vision lenses,” she said.

“ZEISS now offers premium quality optics in finished single vision lenses, combined with fast delivery and affordable pricing to ensure everyone can access the benefits of ZEISS optics.”

Learn more about ZEISS ClearView FSV lenses here.

More reading

Why this Melbourne practice chose ZEISS for its premium lens offering

ZEISS builds blue light blocking tech into next-gen lens

Corporate responsibility: Upholding the common good

Related Posts

Globally, more than 196 million people have AMD. Image: Jum/stock.adobe.com.

Aussie study pinpoints key genetic changes in AMD risk

by Staff Writer
December 12, 2025

Australian researchers have for the first time pinpointed specific genetic changes that increase the risk of severe, sight-threatening forms of...

Almost 90% of medical trainees have rated their training highly in the latest MTS. Image: Ai design/stock.adobe.com.

Medical trainees point to unacceptable behaviour in health system

by Staff Writer
December 12, 2025

Medical trainees have rated the quality of their medical training highly in the latest Medical Training Survey, but the rate...

A new Certificate in Advanced Ocular Therapeutics will equip optometrists for regulatory changes currently under consideration by OBA. Image: ACO

Registrations open for new and returning ACO certificate courses

by Staff Writer
December 11, 2025

Registrations are now open for the Australian College of Optometry (ACO) certificate courses in 2026, including a new Certificate in...

Join our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.

Subscribe to our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

About Insight

  • About
  • Advertise
  • Subscribe
  • Contact
  • Terms & Conditions
  • Privacy Collection Notice
  • Privacy Policy

Popular Topics

  • Business
  • Feature
  • Research
  • Technology
  • Therapies
  • Classifieds

© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

No Results
View All Results
NEWSLETTER
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
  • About Us
  • Advertise with Insight
  • Subscribe
  • Contact Insight

© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited